-
Featured
Identifying Risk Factors for Type 2 Myocardial Infarction
In one of the first large systematic surveys of the frequency and implications of supply/demand-related Type 2 Myocardial Infarction, a suite of risk factors has been identified to help ensure patients receive proper care.
-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
DNA is not Destiny When it Comes to Heart Attack Risk
A study led by Sekar Kathiresan, MD, of Mass General, has found that having a favorable lifestyle can help those with a high genetic risk of having a heart attack reduce their risk by over 50%.
-
The Future of the Cardiac Intensive Care Unit
David Dudzinski, MD, director of the Heart Center Intensive Care Unit, discusses how his team combines the specialties of cardiology intensive care, cardiac anesthesia and cardiac surgery into a unified care team model to take care of the entire span of patients of acute, critical, cardiovascular illness.
-
#AHA18: Scientific Sessions in Summary
Mass General physicians answer the question: "What was the most interesting topic presented at this year's Scientific Sessions?"
-
Specific microRNAs Linked to Post-MI Remodeling
By studying a large cohort of patients who had cardiac MRI after myocardial infarction, scientists at Massachusetts General have demonstrated the association of microRNAs with specific features of left ventricular remodeling, suggesting it may someday be possible to pinpoint early biomarkers of heart failure.
Myocardial Infarction contributors
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Position Paper: Distinguish Type 1 and Type 2 MI in Readmission Reduction Program
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
#AHA18 on Twitter: New Cholesterol Guidelines, the PIONEER-HF Trial and More
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Instructor of Medicine, Harvard Medical School
Recent Article
#AHA18: Scientific Sessions in Summary
-
Sekar Kathiresan, MD
Director of the Center for Genomic Medicine , Ofer and Shelley Nemirovsky MGH Research Scholar, Director of the Cardiovascular Disease Initiative at the Broad institute
Recent Article
Apple Watch EKG App Detects Atrial Fibrillation
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
